thiophenes has been researched along with B-Cell Chronic Lymphocytic Leukemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CI; Johnston, JB; Kakar, S; Lau, A; Le, LW; Levina, O; Paul, H; Queau, M; Smith, DA; Snitzler, S; Trudel, S; Wang, T; Wei, EN | 1 |
| Bachireddy, P; Brooks, AN; Buonamici, S; Burger, JA; Carrasco, RD; Davids, MS; Deng, J; Ghia, EM; Gill, AL; Gruber, M; Kim, E; Kipps, TJ; Letai, A; Meyerson, ML; Neuberg, D; Rassenti, LZ; Reed, R; Regis, FFD; Seiler, M; Smith, P; Sun, J; Ten Hacken, E; Thomas, M; Valentin, R; Wang, L; Werner, L; Wong, J; Wu, CJ; Yin, S; Zheng, M | 1 |
| Hwang, CK; Kim, BJ; Kolomeyer, AM | 1 |
| Cottam, HB; Endo, T; Enzler, T; Fukuda, T; James, DF; Karin, M; Kipps, TJ; Nishio, M | 1 |
| Chu, P; Hamada, H; Kato, K; Kipps, TJ; Takahashi, S | 1 |
1 review(s) available for thiophenes and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature.
Topics: Adenine; Administration, Topical; Aged; Anterior Chamber; Antihypertensive Agents; Antineoplastic Agents; Brimonidine Tartrate; Cataract Extraction; Humans; Intraocular Pressure; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Phacoemulsification; Piperidines; Prednisolone; Pyrazoles; Pyrimidines; Sulfonamides; Syndrome; Thiophenes; Timolol; Treatment Outcome; Visual Acuity | 2018 |
1 trial(s) available for thiophenes and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
A phase 2 study of ofatumumab (Arzerra
Topics: Administration, Oral; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Progression-Free Survival; Proto-Oncogene Proteins c-akt; Pyrazoles; Remission Induction; Thiophenes | 2019 |
3 other study(ies) available for thiophenes and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies.
Topics: Adult; Aged; Aged, 80 and over; Alternative Splicing; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epoxy Compounds; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Macrolides; Male; Mice; Mice, Transgenic; Middle Aged; Mitochondria; Mutation; Myeloid Cell Leukemia Sequence 1 Protein; Phosphoproteins; Primary Cell Culture; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; RNA Splicing Factors; Spliceosomes; Sulfonamides; Thiophenes | 2018 |
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
Topics: B-Cell Activating Factor; B-Cell Maturation Antigen; Carboxylic Acids; Cell Fractionation; Cell Survival; Flow Cytometry; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; NF-kappa B; Protein Kinase Inhibitors; Sensitivity and Specificity; Signal Transduction; Thiophenes; Transmembrane Activator and CAML Interactor Protein; Tumor Necrosis Factor Ligand Superfamily Member 13 | 2007 |
Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.
Topics: CD27 Ligand; Dose-Response Relationship, Drug; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Metalloproteases; Phenotype; Phenylalanine; Protease Inhibitors; Solubility; T-Lymphocytes; Thiophenes; Tumor Necrosis Factor Receptor Superfamily, Member 7 | 2007 |